Assurant
AIZ NYSE Multi-line Insurance Financials FY2016βFY2025
Assurant's revenue rose 7.9% to $12.8 billion in fiscal 2025. Its net margin was 6.8%, up from 6.4% a year earlier. Free cash flow was $1.6 billion, up 43.8%. It paid out $472 million in dividends and buybacks, 30% of free cash flow. The diluted share count fell 1.9%.
About these figures. Debt is Assurant's senior notes, its only debt on the balance sheet.
What Assurant does
No business description yet.
- Legal name
- Assurant, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001267238-26-000010
0001267238
Revenue and margins
Assurant had $12.8B of revenue in fiscal 2025, up 7.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 7.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.6B in fiscal 2025, 12.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Assurant returned $472M to shareholders in fiscal 2025, 30% of free cash flow. The diluted share count fell 1.9%.
Value Assurant yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $6.7M and divides by 51.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 13.6x Β· peers 13.4x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Assurant can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.3B | $1.7B | $1.9B | $2.1B | $2.2B |
| Debt incl. finance leases | $2.2B | $2.1B | $2.1B | $2.1B | $2.2B |
| Net debt / EBITDA | β0.1x | 0.7x | 0.2x | 0.0x | 0.0x |
| Debt / equity | 0.4x | 0.5x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 7.9x | 4.2x | 8.5x | 9.7x | 10.9x |
| Total assets | $33.9B | $33.1B | $33.6B | $35.0B | $36.3B |
| Total liabilities | $28.5B | $28.9B | $28.8B | $29.9B | $30.4B |
| Shareholders' equity | $5.5B | $4.2B | $4.8B | $5.1B | $5.9B |
| Net debt (β = net cash) | β$86.1M | $438M | $195M | β$6.2M | β$6.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$11.0M
6 insiders
Of sales under plans
75%
$8.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Nair BijuEVP, Pres, Global Conn Living | Sold | 3,931 | $302.46 | $1.2M | Form 4 |
| Jun 22, 2026 | Robert LonerganEVP, Csto | Sold plan | 7,000 | $262.71 | $1.8M | Form 4 |
| May 26, 2026 | Dimitry DiRienzoSVP, CAO, Controller | Sold | 2,000 | $255.68 | $0.5M | Form 4 |
| May 15, 2026 | Keith MeierEVP, Chief Financial Officer | Sold plan | 25,000 | $254.31 | $6.4M | Form 4 |
| May 14, 2026 | Jay RosenblumEVP, Chief Legal Officer | Sold | 2,000 | $251.77 | $0.5M | Form 4 |
| Mar 20, 2026 | Dimitry DiRienzoSVP, CAO, Controller | Sold | 750 | $210.98 | $0.2M | Form 4 |
| Mar 20, 2026 | Subhashish SenguptaEVP, Chief People Officer | Sold | 1,880 | $210.53 | $0.4M | Form 4 |
| Mar 19, 2026 | Subhashish SenguptaEVP, Chief People Officer | Sold | 20 | $215.00 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β1.5% | β1.7% | β2.7% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Assurant AIZ | $14.2B | 7.9% | β | 12.5% | 17.5% | 13.6x | β | |
| Loews L | $23.0B | 5.4% | β | 14.6% | 9.5% | 13.7x | β | Compare β |
| American Financial Group AFG | $12.5B | β1.8% | 13.1% | β | 17.8% | 13.2x | β | Compare β |
| American International Group AIG | $43.4B | β1.8% | β | β | 9.3% | 14.9x | β | Compare β |
| RenaissanceRe RNR | $14.6B | 9.9% | β | β | 54.2% | 6.3x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.5B | $6.4B | $8.1B | $9.6B | $9.6B | $10.2B | $10.2B | $11.1B | $11.9B | $12.8B |
| Interest expense | $57.6M | $49.5M | $100M | $111M | $105M | $112M | $108M | $108M | $107M | $110M |
| Pretax income | $849M | $445M | $334M | $455M | $578M | $771M | $350M | $807M | $927M | $1.1B |
| Income tax | $283M | β$75.1M | $80.9M | $148M | $58.7M | $168M | $73.3M | $164M | $167M | $215M |
| Net income | $565M | $520M | $251M | $383M | $441M | $1.4B | $277M | $643M | $760M | $873M |
| Diluted EPS | $9.13 | $9.39 | $3.98 | $5.84 | $6.98 | $22.66 | $5.05 | $11.95 | $14.46 | $16.93 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $109M | $530M | $657M | $1.4B | $1.3B | $782M | $597M | $1.1B | $1.3B | $1.8B |
| Capital expenditure | $85.2M | $62.1M | $82.8M | $110M | $121M | $187M | $186M | $203M | $221M | $236M |
| Free cash flow | $23.4M | $468M | $574M | $1.3B | $1.2B | $594M | $411M | $936M | $1.1B | $1.6B |
| Depreciation and amortization | $125M | $116M | $127M | $126M | $142M | $172M | $182M | $196M | $224M | $250M |
| Stock-based compensation | $41.6M | $35.5M | $57.1M | $55.9M | $57.9M | $66.7M | $62.6M | $75.1M | $81.1M | $85.7M |
| Acquisitions | $63.2M | $129M | $1.1B | $7.6M | $459M | $16.6M | $72.5M | $0.3M | $12.9M | $23.5M |
| Share buybacks | $863M | $389M | $139M | $272M | $297M | $839M | $573M | $193M | $307M | $304M |
| Dividends paid | $125M | $119M | $134M | $151M | $155M | $158M | $150M | $152M | $156M | $168M |
| Dividends and buybacks | $988M | $508M | $273M | $423M | $452M | $997M | $723M | $345M | $463M | $472M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.3B | $1.3B | $1.6B | $2.3B | $2.5B | $2.3B | $1.7B | $1.9B | $2.1B | $2.2B |
| Total debt | $1.1B | $1.1B | $2.0B | $2.0B | $2.3B | $2.2B | $2.1B | $2.1B | $2.1B | $2.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $344M | $348M | $393M | $434M | $446M | $561M | $645M | $686M | $768M | $842M |
| Total assets | $29.7B | $31.8B | $41.1B | $44.3B | $44.6B | $33.9B | $33.1B | $33.6B | $35.0B | $36.3B |
| Total liabilities | $25.6B | $27.6B | $36.0B | $38.6B | $38.7B | $28.5B | $28.9B | $28.8B | $29.9B | $30.4B |
| Shareholders' equity | $4.1B | $4.3B | $5.1B | $5.7B | $6.0B | $5.5B | $4.2B | $4.8B | $5.1B | $5.9B |
| Margins | ||||||||||
| EBITDA margin | 13.7% | 9.5% | 7.0% | 7.2% | 8.6% | 10.4% | 6.3% | 10.0% | 10.6% | 11.3% |
| Net margin | 7.5% | 8.1% | 3.1% | 4.0% | 4.6% | 13.4% | 2.7% | 5.8% | 6.4% | 6.8% |
| FCF margin | 0.3% | 7.3% | 7.1% | 13.6% | 12.7% | 5.8% | 4.0% | 8.4% | 9.4% | 12.5% |
| Returns | ||||||||||
| Return on capital | 15.5% | 12.4% | 6.9% | 7.0% | 11.1% | 12.5% | 7.2% | 15.1% | 16.8% | 17.5% |
| Return on equity | 13.1% | 12.4% | 5.4% | 7.1% | 7.6% | 23.9% | 5.7% | 14.2% | 15.3% | 15.9% |
| Return on assets | 1.9% | 1.7% | 0.7% | 0.9% | 1.0% | 3.5% | 0.8% | 1.9% | 2.2% | 2.5% |
| Growth | ||||||||||
| Revenue growth | β27.1% | β14.8% | 25.6% | 18.8% | 0.3% | 6.2% | 0.1% | 9.2% | 6.7% | 7.9% |
| Net income growth | 299.3% | β8.1% | β51.7% | 52.4% | 15.2% | 208.9% | β79.7% | 132.3% | 18.3% | 14.8% |
| EPS growth | 345.4% | 2.9% | β57.6% | 46.7% | 19.5% | 224.6% | β77.7% | 136.6% | 21.0% | 17.1% |
| FCF growth | β79.7% | 1,901.3% | 22.6% | 127.1% | β6.3% | β51.3% | β30.9% | 127.9% | 18.8% | 43.8% |
| Share count change | β10.3% | β10.7% | 7.7% | 4.7% | 1.4% | β4.8% | β8.9% | β2.9% | β2.2% | β1.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.2x | β0.4x | 0.7x | β0.4x | β0.3x | β0.1x | 0.7x | 0.2x | 0.0x | 0.0x |
| Debt / equity | 0.3x | 0.3x | 0.4x | 0.4x | 0.4x | 0.4x | 0.5x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 15.7x | 10.0x | 4.3x | 5.1x | 6.5x | 7.9x | 4.2x | 8.5x | 9.7x | 10.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 1.0% | 1.0% | 1.2% | 1.3% | 1.8% | 1.8% | 1.8% | 1.9% | 1.8% |
| Stock comp / revenue | 0.6% | 0.6% | 0.7% | 0.6% | 0.6% | 0.7% | 0.6% | 0.7% | 0.7% | 0.7% |
| Payouts / FCF | 4,223.9% | 108.5% | 47.6% | 32.5% | 37.0% | 167.7% | 176.1% | 36.9% | 41.7% | 29.5% |
| Quality scores | ||||||||||
| Accruals ratio | 1.5% | β0.0% | β1.1% | β2.4% | β2.0% | 1.5% | β1.0% | β1.5% | β1.7% | β2.7% |
Source: SEC EDGAR XBRL filings (CIK 0001267238). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.